Re:Anti-addiction drug maker found a captive market in the c...
by rocqua on Friday June 30, 2017 @08:18PM
(#14674444)
I'd say that on-scene pain management is a luxury compared to fixing an opioid addiction. (Maybe the desensitization makes pain management harder anyway).
A drug addict seems more likely to suffer from his addiction than to suffer from an accident.
I am basing this on the assumption that naltrexone will only delay pain treatment by a day at most. If it has people in agonizing pain until it wears off things are different.
A drug addict seems more likely to suffer from his addiction than to suffer from an accident. I am basing this on the assumption that naltrexone will only delay pain treatment by a day at most. If it has people in agonizing pain until it wears off things are different.